Connection

Laurent Peyrin-Biroulet to Drug Approval

Back to Details
This is a "connection" page, showing publications Laurent Peyrin-Biroulet has written about Drug Approval.
Laurent Peyrin-Biroulet
Connection Strength
0.046
Drug Approval
  1. Vedolizumab for the treatment of inflammatory bowel diseases: from symptomatic control to mucosal healing. Immunotherapy. 2019 05; 11(7):565-575.
    View in: PubMed
    Score: 0.024
  2. Clinical development of biologicals and biosimilars - safety concerns. Expert Rev Clin Pharmacol. 2017 06; 10(6):567-569.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.